HomeFREA • FRA
add
Fresenius SE ADR
Previous close
€9.50
Day range
€9.60 - €9.70
Year range
€5.95 - €9.80
Market cap
22.28B EUR
Avg Volume
7.00
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 5.63B | -0.85% |
Operating expense | 946.00M | -19.49% |
Net income | 264.00M | 143.00% |
Net profit margin | 4.69 | 143.39% |
Earnings per share | — | — |
EBITDA | 724.00M | 163.75% |
Effective tax rate | 32.42% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.49B | -41.89% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 19.40B | — |
Shares outstanding | 694.74M | — |
Price to book | 0.28 | — |
Return on assets | — | — |
Return on capital | 3.58% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 264.00M | 143.00% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Fresenius SE & Co. KGaA is a German multinational health care company based in Bad Homburg vor der Höhe. It provides products and services for dialysis in hospitals, as well as inpatient and outpatient medical care. The company is involved in hospital management and in engineering and services for medical centers and other health care facilities.
The company is ranked 411th in the Forbes Global 2000 list in 2023.
In March 2022, it announced plans to merge with InterWell Health and Cricket Health to form a new company, which will operate under the InterWell Health brand, focused on services for the earlier stages of kidney disease. Wikipedia
Founded
1912
Headquarters
Website
Employees
177,091
